Rodney Carter

Rodney Carter has a diverse and extensive work experience in the field of clinical operations. Rodney is currently serving as the Director of Clinical Operations at Corbus Pharmaceuticals since April 2023. Prior to that, they worked at Novocure as an Associate Director of Global Clinical Operations from September 2022 to April 2023.

Before joining Novocure, Rodney held multiple roles at Nanobiotix. Rodney was an Associate Director of Clinical Operations from July 2020 to September 2022, and prior to that, they served as a Senior Clinical Operations Manager from August 2019 to July 2020.

Rodney's work history also includes positions at IQVIA, where they worked as a Clinical Project Manager from December 2018 to August 2019 and as a Senior Clinical Lead from March 2017 to December 2018.

Rodney was a Clinical Team Lead at Worldwide Clinical Trials from November 2016 to March 2017 and a Clinical Operations Leader at Parexel from January 2015 to November 2016.

Rodney started their career as a Clinical Research Consultant at Duke Clinical Research Institute from January 2014 to January 2015. Prior to that, they worked as a Senior CRA III at IQVIA from February 2008 to January 2014 and as a CRA III at PPD from July 2004 to February 2008.

Rodney began their professional journey at Almac Group as a Project Coordinator from June 2001 to July 2004.

Rodney Carter obtained a Bachelor of Science degree from East Carolina University. No further details regarding their education history are available.